Why the study?
Does quinidine at steady state compared to a single dose alter its pharmacokinetics and pharmacodynamics?
Does quinidine at steady state compared to a single dose alter its pharmacokinetics and pharmacodynamics?
Quinidine exhibits time-dependent pharmacokinetics and pharmacodynamics, with lower clearance and a steeper concentration-QTc relationship at steady state compared to a single dose.
Answers are grounded in this paper and cite their sources.
May warrant closer QTc monitoring at quinidine steady state; leaves open validation in larger cohorts.
The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine based upon measurements of total and unbound serum concentrations were determined after a single dose (400 mg) and at steady state (200 mg every 6 h). 2. The oral clearance (7.6 +/- 1.9 vs 4.8 +/- 2.0 ml min-1 kg-1; P less than 0.05) and renal clearance (1.2 +/- 0.3 vs 0.63 +/- 0.25 ml min-1 kg-1; P less than 0.005) or quinidine were lower during steady state than after the single dose. 3. The area under the serum concentration vs time curve (AUC) of 3-hydroxyquinidine was greater at steady state than after the single dose (2.0 +/- 0.7 vs 3.0 +/- 0.6 mg l-1 h; P less than 0.05) and its renal clearance was less (3.0 +/- 1.1 vs 1.54 +/- 0.38 ml min-1 kg-1; P less than 0.05). 4. The slope of the relationship between quinidine concentration and change in QTc interval was greater at steady state (40.1 +/- 21.7 vs 72.2 +/- 41.7 ms/(mg l-1); P less than 0.05).
No takes yet. Share an insight, caveat, or question.
Wooding‐Scott et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: